These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26169626)

  • 1. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
    Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.
    Mourik K; Decrescenzo P; Brucato G; Gill KE; Arndt L; Kimhy D; Keilp JG; Girgis RR
    Early Interv Psychiatry; 2017 Jun; 11(3):250-254. PubMed ID: 26663764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes.
    Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS
    Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis.
    Hedges EP; See C; Si S; McGuire P; Dickson H; Kempton MJ
    Psychol Med; 2022 Aug; 52(11):2009-2016. PubMed ID: 35821623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of neurocognitive function in individuals at-risk for psychosis.
    Keefe RS; Perkins DO; Gu H; Zipursky RB; Christensen BK; Lieberman JA
    Schizophr Res; 2006 Dec; 88(1-3):26-35. PubMed ID: 16930949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood Maltreatment and Its Association with Cognitive Ability in Young People Suspected to Be at Clinical High Risk of Psychosis.
    Büetiger JR; Michel C; Kaess M; Kindler J
    Psychopathology; 2023; 56(1-2):17-28. PubMed ID: 35660706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Assessments Are More Important Among Adolescents Than Adults for Predicting Psychosis in Clinical High Risk.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Chen T; Li C; Wang J
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jan; 7(1):56-65. PubMed ID: 34274517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
    Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
    Zhang T; Wei Y; Cui H; Tang X; Xu L; Hu Y; Tang Y; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2023 Sep; 327():115385. PubMed ID: 37567111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis.
    Woodberry KA; McFarlane WR; Giuliano AJ; Verdi MB; Cook WL; Faraone SV; Seidman LJ
    Schizophr Res; 2013 May; 146(1-3):87-94. PubMed ID: 23434505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Piskulic D; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Schizophr Res; 2016 Mar; 171(1-3):176-81. PubMed ID: 26785807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affect recognition in people at clinical high risk of psychosis.
    Addington J; Piskulic D; Perkins D; Woods SW; Liu L; Penn DL
    Schizophr Res; 2012 Sep; 140(1-3):87-92. PubMed ID: 22763425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.
    Millman ZB; Roemer C; Vargas T; Schiffman J; Mittal VA; Gold JM
    Schizophr Bull; 2022 Sep; 48(5):999-1010. PubMed ID: 35333372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis.
    Carrión RE; Goldberg TE; McLaughlin D; Auther AM; Correll CU; Cornblatt BA
    Am J Psychiatry; 2011 Aug; 168(8):806-13. PubMed ID: 21536691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.